Seek Returns

Agilent (A) Stock Analysis

This is a peer-relative look at Agilent (A): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Pharmaceuticals, Biotechnology & Life Sciences peers, so every number reads in context rather than in isolation.

Company Profile

Company profile fields for Agilent (A)
Profile ItemA
NameAgileThought, Inc. Class A Common Stock
Country/RegionUnited States
GICS SectorHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & Services
Market Capitalization49.28 billion USD
CurrencyUSD
ExchangeNYSE
Listing DateNovember 18, 1999
Security TypeCommon Stock

Price Performance

Cumulative Growth

A
GSPC
Loading price history…
Agilent (A) vs. S&P 500 (GSPC): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Agilent (A) and S&P 500 (GSPC). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Agilent (A) and S&P 500 (GSPC). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Agilent (A) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: AIndustry group median
Total Return (1Y)22.92%24.62%
Total Return (3Y, Annualized)19.33%20.37%
Total Return (5Y, Annualized)3.03%-4.02%

Risk Profile

Drawdown History

A
GSPC
Loading price history…
Agilent (A) vs. S&P 500 (GSPC): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Agilent (A) and S&P 500 (GSPC). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Agilent (A) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: AIndustry group median
Volatility (1Y, Annualized)33.10%66.36%
Beta (5Y)1.220.93
Max Drawdown (5Y)-38.09%-80.19%

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
Each dot is a stock plotted by 1-year volatility (risk) and 1-year return. A is highlighted; the dashed line is the Capital Allocation Line from the risk-free rate through the industry median — dots above it are stronger on a risk-adjusted basis.

Risk-Adjusted Metrics

Agilent (A) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: AIndustry group median
Sharpe Ratio (1Y)0.560.36
Sortino Ratio (1Y)0.960.58

Profitability

ROE (TTM)

Agilent (A) posts ROE of 20.97%, in the upper peer quartile. That suggests the company earns more from each dollar of shareholders’ equity than most industry peers, a useful capital-efficiency signal.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.97%

Group distribution
Max
109.18%
A
20.97%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Largest peers
LLY
86.02%
NVS
24.33%
AZN
22.57%
A
20.97%
JNJ
20.02%
MRK
5.06%
ABBV
--
Loading chart…
Where Agilent (A) stands on ROE within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Net Margin (TTM)

Agilent (A) keeps 19.53% of revenue as net profit on net margin, above the industry benchmark range. That is unusually strong bottom-line conversion, though tax effects, asset sales, or other one-off gains should be checked before treating it as durable.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

19.53%

Group distribution
A
19.53%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Largest peers
LLY
31.90%
A
19.53%
AZN
17.68%
NVS
17.49%
JNJ
16.20%
ABBV
15.67%
MRK
3.64%
Loading chart…
Where Agilent (A) stands on net margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Operating Margin (TTM)

Agilent (A) turns 25.56% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

25.56%

Group distribution
Max
83.12%
A
25.56%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Largest peers
LLY
53.66%
ABBV
39.59%
MRK
35.22%
NVS
34.27%
AZN
29.57%
JNJ
25.74%
A
25.56%
Loading chart…
Where Agilent (A) stands on operating margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Profitability Metrics

Agilent (A) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: AIndustry group median
ROE (TTM)20.97%-26.66%
ROA (TTM)8.63%-12.50%
Net Margin (TTM)19.53%0.00%
Operating Margin (TTM)25.56%0.00%
Gross Margin (TTM)53.65%37.87%

Growth

Revenue Growth

Agilent (A) grew revenue 6.73%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.

Loading chart…
Agilent (A): Revenue Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

EPS Growth

Agilent (A) grew earnings per share 3.16%, roughly around the peer group's normal range. Bottom-line momentum looks broadly typical for the industry.

Loading chart…
Agilent (A): EPS Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

Growth Metrics

Agilent (A) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: AIndustry group median
Revenue Growth (YoY)6.73%11.45%
Revenue Growth (3Y CAGR)0.48%9.94%
EPS Growth (YoY)3.16%4.28%
EPS Growth (3Y CAGR)3.02%4.17%

Financial Strength

Current Ratio (MRQ)

Agilent (A) has current ratio of 2.05, in the tighter-liquidity quartile for its industry. The short-term cushion is thinner than most peers carry, even if the absolute comfort level still depends on the business model.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.05

Group distribution
Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
A
2.05
Min
0.10
Largest peers
A
2.05
LLY
1.39
MRK
1.35
JNJ
1.02
AZN
1.01
NVS
0.88
ABBV
0.87
Loading chart…
Where Agilent (A) stands on current ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Debt / Equity (MRQ)

Agilent (A) has debt-to-equity ratio of 0.56, roughly in line with the peer group’s normal leverage range. Its mix of debt and equity looks typical for the industry.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.56

Group distribution
Max
1.42
Q3
0.65
A
0.56
Median
0.15
Q1
0.02
Min
0.00
Largest peers
NVS
1.29
LLY
1.23
MRK
1.20
AZN
0.66
A
0.56
JNJ
0.55
ABBV
--
Loading chart…
Where Agilent (A) stands on debt-to-equity ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Financial Strength Metrics

Agilent (A) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: AIndustry group median
Current Ratio (MRQ)2.055.52
Debt / Equity (MRQ)0.560.15
Net Debt / EBITDA1.151.08

Dividends

Dividend Yield (TTM)

Agilent (A) has dividend yield of 0.59%, above the entire industry range. That headline income is large, but yields this far above peers often come from a falling share price or an at-risk payout, so dividend safety matters more than the percentage itself.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.59%

Group distribution
A
0.59%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
NVS
2.88%
ABBV
2.40%
MRK
2.29%
JNJ
1.94%
AZN
1.73%
A
0.59%
LLY
0.49%
Loading chart…
Where Agilent (A) stands on dividend yield within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Payout Ratio (TTM)

Agilent (A) has payout ratio of 19.98%, above the peer distribution for its industry. The dividend consumes more reported earnings than peers normally do, leaving unusually thin earnings cover.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

19.98%

Group distribution
A
19.98%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
MRK
343.43%
ABBV
117.35%
NVS
90.46%
JNJ
80.12%
AZN
45.38%
LLY
21.71%
A
19.98%
Loading chart…
Where Agilent (A) stands on payout ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Metrics

Agilent (A) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: AIndustry group median
Dividend Yield (TTM)0.59%0.00%
Dividend Payout Ratio (TTM)19.98%0.00%

Valuation

P/E Ratio (TTM)

Agilent (A) trades at P/E ratio of 34.47, near the industry’s usual earnings multiple. The stock is not showing a clear peer discount or premium on trailing earnings.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

34.47

Group distribution
Max
85.34
Q3
43.46
A
34.47
Median
26.69
Q1
13.30
Min
0.07
Largest peers
MRK
148.21
ABBV
50.05
LLY
43.95
JNJ
41.92
A
34.47
NVS
31.02
AZN
26.37
Loading chart…
Where Agilent (A) stands on P/E ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/S Ratio (TTM)

Agilent (A) trades at 6.68 on P/S ratio, roughly in the peer group’s normal range. The market is not making a strong cheap-or-rich statement about its revenue base.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.68

Group distribution
Max
58.18
Q3
25.77
Median
7.30
A
6.68
Q1
3.01
Min
0.01
Largest peers
LLY
13.95
ABBV
7.80
JNJ
6.69
A
6.68
MRK
5.37
NVS
5.35
AZN
4.63
Loading chart…
Where Agilent (A) stands on P/S ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/B Ratio (MRQ)

Agilent (A) trades at 6.69 on P/B ratio, in the higher book-value quartile. The market is paying a premium to book, so stronger ROE, cleaner assets, or a better growth profile need to justify it.

A

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.69

Group distribution
Max
13.53
A
6.69
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
Largest peers
LLY
29.96
NVS
8.25
JNJ
8.16
MRK
8.06
A
6.69
AZN
5.59
ABBV
-112.34
Loading chart…
Where Agilent (A) stands on P/B ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Valuation Metrics

Agilent (A) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: AIndustry group median
P/E Ratio (TTM)34.4726.69
P/S Ratio (TTM)6.687.30
P/B Ratio (MRQ)6.693.25
Free Cash Flow Yield (TTM)2.15%-1.66%